Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated European recommendations for the clinical use of HIV drug resistance testing.
Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, Banhegyi D, Boucher C, Brun-Vézinet F, Camacho R, Clevenbergh P, Clumeck N, Dedes N, De Luca A, Doerr HW, Faudon JL, Gatti G, Gerstoft J, Hall WW, Hatzakis A, Hellmann N, Horban A, Lundgren JD, Kempf D, Miller M, Miller V, Myers TW, Nielsen C, Opravil M, Palmisano L, Perno CF, Phillips A, Pillay D, Pumarola T, Ruiz L, Salminen M, Schapiro J, Schmidt B, Schmit JC, Schuurman R, Shulse E, Soriano V, Staszewski S, Vella S, Youle M, Ziermann R, Perrin L. Vandamme AM, et al. Among authors: vella s. Antivir Ther. 2004 Dec;9(6):829-48. Antivir Ther. 2004. PMID: 15651743
Antiretroviral therapy: state of the HAART.
Vella S, Palmisano L. Vella S, et al. Antiviral Res. 2000 Jan;45(1):1-7. doi: 10.1016/s0166-3542(99)00068-6. Antiviral Res. 2000. PMID: 10774585 Review. No abstract available.
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Van Vaerenbergh K, Van Laethem K, Albert J, Boucher CA, Clotet B, Floridia M, Gerstoft J, Hejdeman B, Nielsen C, Pannecouque C, Perrin L, Pirillo MF, Ruiz L, Schmit JC, Schneider F, Schoolmeester A, Schuurman R, Stellbrink HJ, Stuyver L, Van Lunzen J, Van Remoortel B, Van Wijngaerden E, Vella S, Witvrouw M, Yerly S, De Clercq E, Destmyer J, Vandamme AM. Van Vaerenbergh K, et al. Among authors: vella s. Antimicrob Agents Chemother. 2000 Aug;44(8):2109-17. doi: 10.1128/AAC.44.8.2109-2117.2000. Antimicrob Agents Chemother. 2000. PMID: 10898683 Free PMC article.
HIV therapy in the post-eradication era.
Vella S, Palmisano L. Vella S, et al. J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):34-7. J Biol Regul Homeost Agents. 2000. PMID: 10763890
HIV eradication revisited.
Vella S, Palmisano L. Vella S, et al. Expert Opin Investig Drugs. 2000 Feb;9(2):193-7. doi: 10.1517/13543784.9.2.193. Expert Opin Investig Drugs. 2000. PMID: 11060670
594 results